(3084,9542,10718,145957) // 2066v1

Mei L, Nave KA

Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Neuron 83:27-49 (2014)
DOI:10.1016/j.neuron.2014.06.007

Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, Belzil VV, Dion PA, Higasa K, Doi K, Ishiura H, Mitsui J, Date H, Ahsan B, Matsukawa T, Ichikawa Y, Moritoyo T, Ikoma M, Hashimoto T, Kimura F, Murayama S, Onodera O, Nishizawa M, Yoshida M, Atsuta N, Sobue G, Fifita JA, Williams KL, Blair IP, Nicholson GA, Gonzalez-Perez P, Brown RH Jr, Nomoto M, Elenius K, Rouleau GA, Fujiyama A, Morishita S, Goto J, Tsuji S

ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.

Am J Hum Genet 93:900-5 (2013)
DOI:10.1016/j.ajhg.2013.09.008